Followers

December 19, 2023

Mirum Pharma's liver disease therapy fails in mid-stage study

The drug is a potential treatment for biliary atresia in patients who have undergone surgery in which blocked bile ducts are bypassed to restore normal bile flow.


No comments:

Post a Comment